Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nat Med ; 74(3): 615, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32274686

RESUMO

The article Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula "Goshajinkigan".

2.
J Nat Med ; 73(4): 761-768, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31190267

RESUMO

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the dose-limiting side effects of cancer chemotherapy. Although the control of CIPN is important, it is difficult to manage with currently available therapeutic drugs. Therefore, there is a need for novel therapeutic agents for treating CIPN. Goshajinkigan (GJG) is a Kampo formula composed of ten crude drugs. While GJG has been used for the treatment of CIPN, the active constituents of GJG and their underlying mechanisms of pharmacological effects are still unknown. Our previous study revealed that repetitive oral administration of the water extract of Plantaginis Semen, a crude drug ingredient of GJG, inhibited the mechanical allodynia induced by an intraperitoneal injection of paclitaxel in mice. To elucidate the active compounds of Plantaginis Semen, activity-guided separation of the water extract of Plantaginis Semen was performed. From the active fraction, four iridoids (1-4) were identified. Repetitive oral administration of aucubin (1) at 100 or 30 mg/kg and 100 mg/kg of the fraction crude 3 [primarily comprised of pedicularis-lactone (3)], showed anti-allodynic activity, suggesting 1 and 3 could be some of the active compounds responsible for the anti-allodynic property of Plantaginis Semen and GJG. Our study establishes that oral administration of 1 has potent anti-allodynic effect in addition to the activity of intraperitoneally administered 1 reported previously. Identification of active anti-allodynic compounds found in Kampo formulations will support the development of novel therapies for the management of CIPN in cancer patients.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Hiperalgesia/tratamento farmacológico , Doenças do Sistema Nervoso Periférico/tratamento farmacológico , Extratos Vegetais/farmacologia , Plantago/química , Animais , Hiperalgesia/induzido quimicamente , Glucosídeos Iridoides/farmacologia , Iridoides/farmacologia , Lactonas/farmacologia , Masculino , Medicina Kampo , Camundongos , Camundongos Endogâmicos C57BL , Paclitaxel/uso terapêutico , Doenças do Sistema Nervoso Periférico/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...